What is Immunome's asset turnover?

Immunome (IMNM) reported asset turnover of 0× in Q1 2026.

How has Immunome's asset turnover changed year-over-year?

Immunome's asset turnover decreased by 74.8% year-over-year, from 0× to 0×.

What is the long-term trend for Immunome's asset turnover?

Over 2 years (2023 to 2025), Immunome's asset turnover has grown at a -69.6% compound annual growth rate (CAGR), from 0.2× to 0×.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Immunome IMNM Asset turnover

Asset turnover at other companies

PfizerPFE

0.3×0.0×

Arcus BiosciencesRCUS

0.2×+0.1×

Nuvation BioNUVB

0.3×+0.2×

SELLAS Life Sciences Group, Inc.SLS

0×—

IDEAYA Biosciences, Inc.IDYA

0×0.0×

ImmunityBio, Inc.IBRX

0.3×+0.2×

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Calculated from Immunome’s reported figures.

total revenue/total assets=0×

Based on trailing twelve months.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's asset turnover?: Immunome (IMNM) reported asset turnover of 0× in Q1 2026.
How has Immunome's asset turnover changed year-over-year?: Immunome's asset turnover decreased by 74.8% year-over-year, from 0× to 0×.
What is the long-term trend for Immunome's asset turnover?: Over 2 years (2023 to 2025), Immunome's asset turnover has grown at a -69.6% compound annual growth rate (CAGR), from 0.2× to 0×.
What does asset turnover mean?: Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.